Moyamoya disease: current concepts and future perspectives

S Kuroda, K Houkin - The Lancet Neurology, 2008 - thelancet.com
Moyamoya disease is an uncommon cerebrovascular disease that is characterised by
progressive stenosis of the terminal portion of the internal carotid artery and its main …

[HTML][HTML] Imaging of moyamoya disease and moyamoya syndrome: current status

J Li, M Jin, X Sun, J Li, Y Liu, Y Xi, Q Wang… - Journal of Computer …, 2019 - journals.lww.com
Moyamoya disease (MMD) and Moyamoya syndrome (MMS) are referring to a progressive
steno-occlusive vasculopathy at terminal portions of the bilateral internal carotid arteries and …

Moyamoya disease in China: its clinical features and outcomes

L Duan, XY Bao, WZ Yang, WC Shi, DS Li, ZS Zhang… - Stroke, 2012 - Am Heart Assoc
Background and Purpose—Here we describe the clinical features and outcomes of patients
with moyamoya disease who were surgically treated at a single institution in China. Methods …

[HTML][HTML] Clinical management of moyamoya patients

I Canavero, IG Vetrano, M Zedde, R Pascarella… - Journal of Clinical …, 2021 - mdpi.com
Moyamoya angiopathy (MMA) is a peculiar cerebrovascular condition characterized by
progressive steno-occlusion of the terminal part of the internal carotid arteries (ICAs) and …

Added value of vessel wall magnetic resonance imaging in the differentiation of moyamoya vasculopathies in a non-Asian cohort

M Mossa-Basha, A de Havenon, KJ Becker, DK Hallam… - Stroke, 2016 - Am Heart Assoc
Background and Purpose—Although studies have evaluated the differential imaging of
moyamoya disease and atherosclerosis, none have investigated the added value of vessel …

[HTML][HTML] Neuroimaging assessment in Down syndrome: a pictorial review

M Rodrigues, J Nunes, S Figueiredo… - Insights into …, 2019 - Springer
Down syndrome (DS), or trisomy 21, is the leading genetic cause of intellectual incapacity
worldwide, with a reported incidence of about 1 in 1,000 to 1 in 1,100 live births. Besides the …

Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [15O]-Water Positron Emission Tomography/Magnetic Resonance Imaging …

AP Fan, MM Khalighi, J Guo, Y Ishii, J Rosenberg… - Stroke, 2019 - Am Heart Assoc
Background and Purpose—Noninvasive imaging of brain perfusion has the potential to
elucidate pathophysiological mechanisms underlying Moyamoya disease and enable …

Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging

T Noguchi, M Kawashima, H Irie, T Ootsuka… - European journal of …, 2011 - Elsevier
OBJECTIVE: Arterial spin-labeling (ASL) is a noninvasive magnetic resonance (MR)
imaging method used to obtain brain perfusion information on various cerebrovascular …

Imaging brain collaterals: quantification, scoring, and potential significance

SB Raymond, PW Schaefer - Topics in Magnetic Resonance …, 2017 - journals.lww.com
Leptomeningeal collaterals provide the primary source of perfusion to ischemic brain tissue
following the onset of acute ischemic stroke and are becoming an important imaging …

A novel staging system to evaluate cerebral hypoperfusion in patients with moyamoya disease

H Yin, X Liu, D Zhang, Y Zhang, R Wang, M Zhao… - Stroke, 2018 - Am Heart Assoc
Background and Purpose—The study goal was to evaluate cerebral perfusion in moyamoya
patients with a novel staging system and investigate the association between differences of …